Charles Brandt v. HHS - Influenza, Guillain-Barre syndrome (GBS) (2021)

Charles Brandt, a 76-year-old man, filed a petition for compensation under the National Vaccine Injury Compensation Program on April 11, 2019. He alleged that he suffered from Guillain-Barré syndrome (GBS) as a result of an influenza vaccine administered on September 30, 2017.

The respondent filed a Rule 4(c) report conceding that Mr. Brandt was entitled to compensation.

The respondent stated that Mr. Brandt met the criteria for a Table injury, specifically GBS, with onset within the specified timeframe after a seasonal flu vaccination and no apparent alternative cause.

The medical records also indicated that his GBS had residual effects lasting more than six months. Chief Special Master Brian H.

Corcoran issued a ruling on entitlement on May 22, 2020, finding Mr. Brandt entitled to compensation.

Subsequently, on February 17, 2021, the respondent filed a proffer on award of compensation. The proffer indicated that Mr.

Brandt should be awarded $178,969.98 for all damages, which included $165,000.00 for pain and suffering and $13,969.98 for out-of-pocket medical and related expenses. The respondent represented that Mr.

Brandt agreed with this proffered award. Chief Special Master Corcoran issued a decision on February 17, 2021, awarding the proffered amount as a lump sum payment.

Petitioner was represented by Theodore J. Hong of Maglio Christopher & Toale, PA, and respondent was represented by Adriana Ruth Teitel of the U.S.

Department of Justice.